HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen Spellman Selected Research

Cell Transplantation

1/2024Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation.
1/2021Impact of Epigenomic Hypermethylation at TP53 on Allogeneic Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndromes.
1/2019A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients.
1/2018Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
10/2017KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.
1/2017Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.
1/2017Improved survival after acute graft-versus-host disease diagnosis in the modern era.
11/2016Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.
5/2014Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.
8/2013Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen Spellman Research Topics

Disease

20Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 08/2007
16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 03/2009
10Leukemia
01/2019 - 03/2009
9Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2023 - 07/2009
8Neoplasms (Cancer)
01/2024 - 04/2010
6Hematologic Neoplasms (Hematological Malignancy)
10/2018 - 12/2005
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2012 - 03/2009
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2012 - 03/2009
3Bronchiolitis Obliterans Syndrome
06/2017 - 04/2010
1idiopathic Aplastic anemia
01/2023
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2023
1Pain (Aches)
01/2016
1HIV Infections (HIV Infection)
03/2013
1Sickle Cell Anemia (Hemoglobin S Disease)
08/2012
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2010
1Infections
04/2010
1Autoimmune Diseases (Autoimmune Disease)
04/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2009

Drug/Important Bio-Agent (IBA)

5LigandsIBA
01/2023 - 05/2014
5AntigensIBA
01/2023 - 06/2011
5HLA Antigens (Human Leukocyte Antigens)IBA
01/2023 - 03/2009
5HLA-C Antigens (HLA-C)IBA
10/2018 - 06/2011
5HLA-A Antigens (HLA-A)IBA
10/2018 - 06/2011
3KIR ReceptorsIBA
01/2019 - 01/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2023 - 01/2023
2Peptides (Polypeptides)IBA
01/2023 - 01/2021
2Immunoglobulins (Immunoglobulin)IBA
01/2019 - 10/2017
2HLA-B Antigens (HLA-B)IBA
10/2018 - 10/2017
2Calcineurin InhibitorsIBA
01/2018 - 07/2009
2Tacrolimus (Prograf)FDA LinkGeneric
01/2017 - 08/2012
2Natural Killer Cell ReceptorsIBA
10/2010 - 04/2010
1Fc Receptors (Fc Receptor)IBA
11/2023
1CateninsIBA
11/2023
1Mitochondrial DNA (mtDNA)IBA
10/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1Proteins (Proteins, Gene)FDA Link
01/2023
1EpitopesIBA
01/2021
1Minor Histocompatibility AntigensIBA
01/2021
1SteroidsIBA
10/2018
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2017
1C-Reactive ProteinIBA
11/2016
1AlbuminsIBA
11/2016
1Ferritins (Ferritin)IBA
11/2016
1Filgrastim (Neupogen)FDA Link
01/2016
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
08/2012
1Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2012
1trans-crotonin (CTN)IBA
08/2012
1GTP Phosphohydrolases (GTPases)IBA
04/2010
1CalcineurinIBA
04/2010
1ChemokinesIBA
03/2010
1micaIBA
11/2009
1Rituximab (Mabthera)FDA Link
06/2009
1Histocompatibility Antigens (Histocompatibility Antigen)IBA
06/2009

Therapy/Procedure

17Transplantation
01/2019 - 06/2009
16Cell Transplantation
01/2024 - 12/2005
6Hematopoietic Stem Cell Transplantation
10/2018 - 03/2009
4Therapeutics
01/2021 - 06/2009
3Stem Cell Transplantation
10/2023 - 01/2020
3Donor Selection
10/2017 - 10/2010
2Homologous Transplantation
11/2016 - 06/2009
1Immunotherapy
10/2018
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2018
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2009